Skip to content

Author

H. Marshall

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Surveillance for severe influenza, COVID-19, and RSV in patients admitted to sentinel Australian hospitals in 2025: the Influenza Complications Alert Network (FluCAN) and the Paediatric Active Enhanced Disease Surveillance (PAEDS) system.

Introduction Influenza, coronavirus disease 2019 (COVID-19) and respiratory syncytial virus (RSV) are common acute respiratory infections and are a cause of significant morbidity and mortality. This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza, COVID-19 and RSV in 2025 in a...

Hannah Morgan, Dominic E. Dwyer, Mark Holmes et al. · 0 citations
Open access Oct 2026

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6-17 years: a randomised, active-controlled and placebo-controlled, phase 2b trial.

BACKGROUND Pertussis remains an important public health issue, in part because current vaccines fail to induce potent mucosal immunity against the causative agent, Bordetella pertussis. In contrast, the live attenuated vaccine BPZE1 induces robust nasal secretory IgA (S-IgA) and protects against B pertussis infection i...

S. Faust, J. Céspedes, L. Avila et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.